Switch to:

Vertex Pharmaceuticals Intrinsic Value: Projected FCF

: USD65.59 (As of Today)
View and export this data going back to 1991. Start your Free Trial

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2020-09-22), Vertex Pharmaceuticals's Intrinsic Value: Projected FCF is USD65.59. The stock price of Vertex Pharmaceuticals is USD262.01. Therefore, Vertex Pharmaceuticals's Price-to-Intrinsic-Value-Projected-FCF of today is 4.0.

NAS:VRTX' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 4.03   Med: 18.95   Max: 819.67
Current: 4.04

4.03
819.67

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Vertex Pharmaceuticals was 819.67. The lowest was 4.03. And the median was 18.95.

NAS:VRTX's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
51% of the 196 Companies
in the Biotechnology industry.

( Industry Median: 4.14 vs. NAS:VRTX: 4.04 )

Vertex Pharmaceuticals Intrinsic Value: Projected FCF Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Vertex Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Intrinsic Value: Projected FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.35 -0.51 4.99 21.21 41.24

Vertex Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Intrinsic Value: Projected FCF Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.17 34.91 41.24 51.45 65.59

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Vertex Pharmaceuticals Intrinsic Value: Projected FCF Distribution

* The bar in red indicates where Vertex Pharmaceuticals's Intrinsic Value: Projected FCF falls into.



Vertex Pharmaceuticals Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Vertex Pharmaceuticals's Free Cash Flow(6 year avg) = USD757.75.

Vertex Pharmaceuticals's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jun20)*0.8)/Shares Outstanding (Diluted Average)
=(14.862653310476*757.74583333333+7519.242*0.8)/263.403
=65.59

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Vertex Pharmaceuticals  (NAS:VRTX) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Vertex Pharmaceuticals's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=262.01/65.593433705353
=3.99

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Vertex Pharmaceuticals Intrinsic Value: Projected FCF Related Terms


Vertex Pharmaceuticals Intrinsic Value: Projected FCF Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)